Illumina Accelerator Boost Capital will invest up to $5m a time in graduates from biotech analysis company Illumina's accelerator programme.
US-based biotechnology analysis firm Illumina secured $40m yesterday in an initial commitment for its Illumina Accelerator Boost Capital fund from investment firm Viking Global Investors.
The fund will support genomic startups graduating from the company’s Illumina Accelerator, matching any amount of funding between $1m and $5m raised from outside investors.
The accelerator, the first to focus on the genomics sector, was launched in October 2014. It consists of a six-month programme that provides startups with seed funding, mentoring, access to…
